Celgene investor relations presentations

Celgene Corporation (NASDAQ: CELG) plans to present at four upcoming investor conferences and events where Celgene management will provide an overview of the Company. The events will be webcast live and will be available in the Investor Relations section of the Company's website at www.celgene.com. Thursday, May 24, 2018, Celgene will host an R&D Deep Dive on Multiple Myeloma at 1:30pm ET Presentation PDF Format Download (opens in new window) PDF 1.02 MB Listen to this Presentation Audio Format Download (opens in new window) Watch this Presentation Video Format Download (opens in new window) View this Presentation PDF Format Download (opens in new window)

Acquisition-Related Tax Information for Celgene Shareholders Click investor alerts to manage event, presentation and SEC Filing email notifications, or select   Jan 2, 2019 “Financial Information” and subheading “SEC Filings” or by contacting Celgene's Investor Relations Department at ir@celgene.com. Mar 19, 2019 Bristol-Myers Squibb, Celgene, and their respective directors and executive officers Appendix C: Our March 6, 2019 Investor Presentation  Mar 19, 2019 Bristol-Myers Squibb Files Investor Presentation Highlighting Significant Benefits of Pending Transaction with Celgene - read this article along  Results highlighted in an oral presentation showed that 51% of patients with please select "Events & Presentations" in the Investor section on Acceleron's  The Investor Relations website contains information about Celgene Corporation business for stockholders, potential investors, and financial analysts.

Mar 19, 2019 Bristol-Myers Squibb Files Investor Presentation Highlighting Significant Benefits of Pending Transaction with Celgene - read this article along 

“Financial Information” and subheading “SEC Filings” or by contacting Celgene’s Investor Relations Department at ir@celgene.com. Certain Information Regarding Participants Bristol-Myers Squibb, Celgene, and their respective directors and executive officers may be considered participants in the solicitation of proxies in connection Celgene Corporation (NASDAQ: CELG) plans to present at four upcoming investor conferences and events where Celgene management will provide an overview of the Company. The events will be webcast live and will be available in the Investor Relations section of the Company's website at www.celgene.com. Thursday, May 24, 2018, Celgene will host an R&D Deep Dive on Multiple Myeloma at 1:30pm ET Presentation PDF Format Download (opens in new window) PDF 1.02 MB Listen to this Presentation Audio Format Download (opens in new window) Watch this Presentation Video Format Download (opens in new window) View this Presentation PDF Format Download (opens in new window) To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. By proceeding further, you acknowledge and agree that your access to information contained in the “Medical and Scientific Conferences Presentations” section of the Biogen website: Is provided for informational purposes for use by the investor community only; and

About the Coca-Cola Company. The Coca-Cola Company (NYSE: KO) is a total beverage company, offering over 500 brands in more than 200 countries and territories.

The Investor Relations website contains information about Vertex Pharmaceuticals's business for stockholders, potential investors, and financial analysts. These documents are available from the Securities and Exchange Commission, the Bristol Myers Squibb website or from Bristol Myers Squibb Investor Relations. In addition, any information contained on this website was current as of the date presented and should not be relied upon as representing our estimates as of any subsequent date. “Financial Information” and subheading “SEC Filings” or by contacting Celgene’s Investor Relations Department at ir@celgene.com. Certain Information Regarding Participants Bristol-Myers Squibb, Celgene, and their respective directors and executive officers may be considered participants in the solicitation of proxies in connection Celgene Corporation (NASDAQ: CELG) plans to present at four upcoming investor conferences and events where Celgene management will provide an overview of the Company. The events will be webcast live and will be available in the Investor Relations section of the Company's website at www.celgene.com. Thursday, May 24, 2018, Celgene will host an R&D Deep Dive on Multiple Myeloma at 1:30pm ET Presentation PDF Format Download (opens in new window) PDF 1.02 MB Listen to this Presentation Audio Format Download (opens in new window) Watch this Presentation Video Format Download (opens in new window) View this Presentation PDF Format Download (opens in new window)

Presentation PDF Format Download (opens in new window) PDF 1.02 MB Listen to this Presentation Audio Format Download (opens in new window) Watch this Presentation Video Format Download (opens in new window) View this Presentation PDF Format Download (opens in new window)

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. By proceeding further, you acknowledge and agree that your access to information contained in the “Medical and Scientific Conferences Presentations” section of the Biogen website: Is provided for informational purposes for use by the investor community only; and

Celgene Corporation (NASDAQ: CELG) plans to present at four upcoming investor conferences and events where Celgene management will provide an overview of the Company. The events will be webcast live and will be available in the Investor Relations section of the Company's website at www.celgene.com. Thursday, May 24, 2018, Celgene will host an R&D Deep Dive on Multiple Myeloma at 1:30pm ET

By proceeding further, you acknowledge and agree that your access to information contained in the “Medical and Scientific Conferences Presentations” section of the Biogen website: Is provided for informational purposes for use by the investor community only; and Learn how Celgene, a global biopharmaceutical company, is committed to improving the lives of patients worldwide by delivering truly innovative and life-changing treatments. Explore the therapies for Hematology, Oncology, Inflammation and Immunology and the medical research to help people live longer, better, and healthier.

These documents are available from the Securities and Exchange Commission, the Bristol Myers Squibb website or from Bristol Myers Squibb Investor Relations. In addition, any information contained on this website was current as of the date presented and should not be relied upon as representing our estimates as of any subsequent date. The Investor Relations website contains information about Vertex Pharmaceuticals's business for stockholders, potential investors, and financial analysts. These documents are available from the Securities and Exchange Commission, the Bristol Myers Squibb website or from Bristol Myers Squibb Investor Relations. In addition, any information contained on this website was current as of the date presented and should not be relied upon as representing our estimates as of any subsequent date. “Financial Information” and subheading “SEC Filings” or by contacting Celgene’s Investor Relations Department at ir@celgene.com. Certain Information Regarding Participants Bristol-Myers Squibb, Celgene, and their respective directors and executive officers may be considered participants in the solicitation of proxies in connection